Related Experiment Video

Updated: Nov 10, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.3K

The Future of Clinical Trial Design in Oncology

Anna Spreafico1,2, Aaron R Hansen1,2, Albiruni R Abdul Razak1,2

  • 1Division of Medical Oncology and Hematology, Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Cancer Discovery
|April 3, 2021
PubMed

Insights

Next-generation oncology clinical trials are evolving towards adaptive, biomarker-driven studies for targeted therapies. This shift aims to enhance efficiency, scientific impact, and patient value in cancer drug development.

Area of Science:

  • Oncology
  • Clinical Trial Design
  • Translational Medicine

Background:

  • Clinical trials are crucial for oncology drug development, moving from histology-based chemotherapy to targeted and immune therapies.
  • Modern trials increasingly use adaptive designs and biomarkers to evaluate novel agents in specific patient populations.

Purpose of the Study:

  • To review scientific, methodological, practical, and patient-centered considerations for transforming oncology clinical trials.
  • To propose a framework for next-generation clinical trials balancing efficiency, scientific rigor, and patient benefit.

Main Methods:

  • Review of current trends in oncology clinical trial design.
  • Discussion of innovative technologies and dynamic design methodologies.
  • Analysis of stakeholder roles (investigators, patients) in advancing cancer research.

Main Results:

  • Oncology trials are shifting towards precision medicine approaches.
  • Adaptive and biomarker-driven designs are becoming standard.
  • A need exists for a structured framework for future trial development.

Conclusions:

  • The future of cancer clinical trials necessitates a framework for rapid translation of scientific discoveries into clinical practice.
  • Next-generation trials will leverage innovative technologies and adaptive designs for personalized patient strategies.
  • Collaborative efforts among all stakeholders are essential for collective learning and advancing oncology research.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

17.7K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
236
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K